产品简要
公司名称 :
北京义翘神州
产品类型 :
蛋白
产品名称 :
A型流感H1N1(A/波多黎各/8/1934)血凝素/血球凝集素蛋白(ECD, 多聚组氨酸标签)
目录 :
11684-V08H
规格 :
100微克
价格 :
348美元
更多信息或购买 :
文章摘录数: 21
出版应用/物种/样本/稀释参考文献
  • 酶联免疫吸附测定; H1N1亚类
Hu Z, Shi L, Xu N, Wang X, Hu J, Zhao J, et al. Induction of cross-group broadly reactive antibody response by natural H7N9 avian influenza virus infection and immunization with inactivated H7N9 vaccine in chickens. Transbound Emerg Dis. 2020;: pubmed 出版商
  • 酶联免疫吸附测定; H5N1亚类
  • 酶联免疫吸附测定; H1N1亚类
  • 酶联免疫吸附测定; H7N9亚类
Grodeland G, Fossum E, Bogen B. Targeting of HA to chemokine receptors induces strong and cross-reactive T cell responses after DNA vaccination in pigs. Vaccine. 2019;: pubmed 出版商
  • 酶联免疫吸附测定; H1N1亚类
Andersen T, Huszthy P, Gopalakrishnan R, Jacobsen J, Fauskanger M, Tveita A, et al. Enhanced germinal center reaction by targeting vaccine antigen to major histocompatibility complex class II molecules. NPJ Vaccines. 2019;4:9 pubmed 出版商
  • 酶联免疫吸附测定; H1N1亚类
Anderson A, Baranowska Hustad M, Braathen R, Grodeland G, Bogen B. Simultaneous Targeting of Multiple Hemagglutinins to APCs for Induction of Broad Immunity against Influenza. J Immunol. 2018;200:2057-2066 pubmed 出版商
  • 酶联免疫吸附测定; H1N1亚类
Gaya M, Barral P, Burbage M, Aggarwal S, Montaner B, Warren Navia A, et al. Initiation of Antiviral B Cell Immunity Relies on Innate Signals from Spatially Positioned NKT Cells. Cell. 2018;172:517-533.e20 pubmed 出版商
  • 免疫印迹; H1N1亚类
Dai J, Pei D, Wang B, Kuang Y, Ren L, Cao K, et al. A novel DNA vaccine expressing the Ag85A-HA2 fusion protein provides protection against influenza A virus and Staphylococcus aureus. Virol J. 2013;10:40 pubmed 出版商
  • 免疫印迹; H1N1亚类
Wu C, Yeh Y, Chan J, Yang Y, Yang J, Liu M, et al. A VLP vaccine induces broad-spectrum cross-protective antibody immunity against H5N1 and H1N1 subtypes of influenza A virus. PLoS ONE. 2012;7:e42363 pubmed 出版商
Szodoray P, Andersen T, Heinzelbecker J, Imbery J, Huszthy P, Stanford S, et al. Integration of T helper and BCR signals governs enhanced plasma cell differentiation of memory B cells by regulation of CD45 phosphatase activity. Cell Rep. 2021;36:109525 pubmed 出版商
Esterly H, Crilly C, Piszkiewicz S, Shovlin D, Pielak G, Christian B. Toxicity and Immunogenicity of a Tardigrade Cytosolic Abundant Heat Soluble Protein in Mice. Front Pharmacol. 2020;11:565969 pubmed 出版商
Wu G, Yu G, Yu Y, Yang S, Duan Z, Wang W, et al. Chemoreactive-Inspired Discovery of Influenza A Virus Dual Inhibitor to Block Hemagglutinin-Mediated Adsorption and Membrane Fusion. J Med Chem. 2020;63:6924-6940 pubmed 出版商
Grødeland G, Baranowska Hustad M, Abadejos J, Blane T, Teijaro J, Nemazee D, et al. Induction of Cross-Reactive and Protective Antibody Responses After DNA Vaccination With MHCII-Targeted Stem Domain From Influenza Hemagglutinin. Front Immunol. 2020;11:431 pubmed 出版商
Ramírez Salinas G, García Machorro J, Rojas Hernández S, Campos Rodríguez R, De Oca A, Gomez M, et al. Bioinformatics design and experimental validation of influenza A virus multi-epitopes that induce neutralizing antibodies. Arch Virol. 2020;165:891-911 pubmed 出版商
Luganini A, Terlizzi M, Catucci G, Gilardi G, Maffei M, Gribaudo G. The Cranberry Extract Oximacro® Exerts in vitro Virucidal Activity Against Influenza Virus by Interfering With Hemagglutinin. Front Microbiol. 2018;9:1826 pubmed 出版商
Pardi N, Hogan M, Naradikian M, Parkhouse K, Cain D, Jones L, et al. Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses. J Exp Med. 2018;215:1571-1588 pubmed 出版商
Mendoza M, Ballesteros A, Qi Q, Sang L, Shashikumar S, Casares S, et al. Generation and testing anti-influenza human monoclonal antibodies in a new humanized mouse model (DRAGA: HLA-A2. HLA-DR4. Rag1 KO. IL-2R?c KO. NOD). Hum Vaccin Immunother. 2017;: pubmed 出版商
Andersen T, Zhou F, Cox R, Bogen B, Grødeland G. A DNA Vaccine That Targets Hemagglutinin to Antigen-Presenting Cells Protects Mice against H7 Influenza. J Virol. 2017;91: pubmed 出版商
Magnen M, Gueugnon F, Guillon A, Baranek T, Thibault V, Petit Courty A, et al. Kallikrein-Related Peptidase 5 Contributes to H3N2 Influenza Virus Infection in Human Lungs. J Virol. 2017;91: pubmed 出版商
Gupta N, Lainson J, Domenyuk V, Zhao Z, Johnston S, Diehnelt C. Whole-Virus Screening to Develop Synbodies for the Influenza Virus. Bioconjug Chem. 2016;27:2505-2512 pubmed
Shembekar N, Mallajosyula V, Mishra A, Yeolekar L, Dhere R, Kapre S, et al. Isolation of a high affinity neutralizing monoclonal antibody against 2009 pandemic H1N1 virus that binds at the 'Sa' antigenic site. PLoS ONE. 2013;8:e55516 pubmed 出版商
Hütter J, Rödig J, Höper D, Seeberger P, Reichl U, Rapp E, et al. Toward animal cell culture-based influenza vaccine design: viral hemagglutinin N-glycosylation markedly impacts immunogenicity. J Immunol. 2013;190:220-30 pubmed 出版商
Dai J, Pei D, Wang B, Kuang Y, Ren L, Cao K, et al. Molecular adjuvant Ag85A enhances protection against influenza A virus in mice following DNA vaccination. Viruses. 2012;4:3606-24 pubmed 出版商
图像
图像 1 :
北京义翘神州 11684-V08H 图像 1
产品信息
提示 :
Online
目录代码 :
11684-V08H
产品名称 :
A型流感H1N1(A/波多黎各/8/1934)血凝素/血球凝集素蛋白(ECD, 多聚组氨酸标签)
产品类型 :
蛋白
宿主物种 :
HEK293细胞
共轭 :
C多聚组氨酸
规格 :
100微克
标价 :
348美元
基因编号 :
ABD77675.1
产品描述 :
A DNA sequence encoding the Influenza A virus (A/Puerto Rico/8/1934 (H1N1)) hemagglutinin (ABD77675.1) (Met1-Gln528) was expressed fused with a C-terminal polyhistidine tag.
物种摘要 :
H1N1
别名 :
血球凝集素
纯度 :
> 85 % as determined by SDS-PAGE.
缓冲液 :
Lyophilized from sterile 20mM Tris, 150mM NaCl, 0.1M Arginase, 0.1M glutamic acid, 10% Glycine, 0.01% tween20, pH8.5
包装 :
In general, recombinant proteins are provided as lyophilized powder which are shipped at ambient temperature. Bulk packages of recombinant proteins are provided as frozen liquid. They are shipped out with blue ice unless customers require otherwise.
储存 :
Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
更多信息或购买 :
公司信息
北京义翘神州
北京市北京经济技术开发区科创十街18号院9号楼
Order@Sinobiological.com
http://www.sinobiological.cn
400-890-9989
公司总部: 中国
北京义翘神州科技股份有限公司(Sino Biological Inc.)是一家从事生物试剂研发、生产、销售并提供技术服务的生物科技公司,主要业务有重组蛋白、抗体、基因和培养基等产品,以及重组蛋白、抗体的开发和生物分析检测等服务。

义翘科技为全球的药品研发企业和生命科学研究机构提供高质量的生物试剂产品和高水平的技术服务。义翘科技目前生产和销售的现货产品种类超过4.6万种,能够全面满足客户对于最接近人体天然蛋白结构和性质的重组蛋白需求,并覆盖生命科学研究的多个领域,为分子生物学、细胞生物学、免疫学、发育生物学、干细胞研究等基础科研方向和创新药物研发提供“一站式”生物试剂产品和技术服务。

义翘科技的客户涵盖大学、科研院所、医药研发企业等国内外各类生物研发单位。目前公司已经在美国、欧洲建立了子公司,累计客户数量超过5,000个,品牌声誉不断累积,已成为生物试剂行业国内领先的科技公司之一。